Quintiles News

Please select a press release from the list below, or filter and sort to find a specific press release.

Latest Press Release

Quintiles CEO to Present at Barclays Global Healthcare Conference

RESEARCH TRIANGLE PARK, NC – February 27, 2015 – Quintiles CEO Tom Pike will present at the 2015 Barclays Global Healthcare Conference on Tuesday, March 10, 2015 in Miami at the Loews Miami Hotel. The Quintiles presentation will begin at 11:15 a.m. (EST). Investors may access a live audio webcast of the presentation on the Quintiles Investor Relations website at www.quintiles.com/investors . An archived audio version of the presentation will be available later that... Learn More
Published Date: All 2015 2014 2013 2012 2011 2010
Press Release Feb 27, 2015
RESEARCH TRIANGLE PARK, NC – February 27, 2015 – Quintiles CEO Tom Pike will present at the 2015 Barclays Global Healthcare Conference on Tuesday, March 10, 2015 in Miami at the Loews Miami Hotel. The Quintiles presentation will begin at 11:15 a.m. (EST). Investors may access a live audio webcast of the presentation on the Quintiles Investor Relations website at www.quintiles.com/investors. An archived audio version of the presentation will be available later that day. About Quintiles Quintiles (NYSE: Q), a Fortune 500 company, is the world’s largest provider of biopharmaceutical development and commercial outsourcing services. With a network of more than 32,000 employees conducting business in approximately 100 countries, we helped develop or commercialize all of 2013’s top-100...
Read More
Press Release Feb 25, 2015
RESEARCH TRIANGLE PARK, N.C. – February 25, 2015 – Quintiles announced today that it has been named to the 2015 CSO50 by IDG's CSO magazine in recognition of the company’s risk mitigation strategy managing Windows XP security challenges. CSO commended the Quintiles team for its innovative defense-in-depth model which minimized security risks for business-critical applications dependent on Windows XP, delivering secure and segmented platforms while protecting critical company assets. “This was an innovative solution to a problem that presents significant security concerns for many organizations around the world,” said Quintiles Chief Information Security Officer Patricia Collins Weedon. “Quintiles has launched many innovative customer solutions that require our team to think beyond current...
Read More
Press Release Feb 24, 2015
RESEARCH TRIANGLE PARK, NC – February 24, 2015 – Quintiles today announced the appointment of Elgar Peerschke to serve as president, Advisory Services. In this role, Peerschke is responsible for leading Quintiles’ Advisory Services organization and the continued development and delivery of its related services. Bringing more than 25 years of experience to Quintiles, Elgar joins Quintiles from Bain & Company, a global business consulting firm, where he was a senior partner in its Global Healthcare Practice Group and a leading client service partner. Prior to Bain, Elgar spent more than a decade at McKinsey and Company in various leadership roles. “Throughout his career, Elgar has focused on the healthcare industry, providing cutting-edge insight and guidance in boardrooms of...
Read More
Press Release Feb 19, 2015
RESEARCH TRIANGLE PARK, N.C. – February 19, 2015 – Quintiles, the world’s largest biopharmaceutical services company, has been named to FORTUNE magazine’s “World’s Most Admired Companies” list for 2015. Quintiles is ranked third overall in FORTUNE’s Healthcare: Pharmacy and Other Services category with the top ranking for the reputation attribute of “global competitiveness” and second within the segment for its “people management.” FORTUNE's World's Most Admired Companies list is the definitive report card on corporate reputations. Since 1997, Fortune has identified, selected and ranked the World’s Most Admired Companies, uncovering the business practices that make these companies highly regarded among their peers. “I would like to congratulate Quintiles’ employees around the world for...
Read More
Press Release Feb 10, 2015
RESEARCH TRIANGLE PARK, N.C. – February 10, 2015 – Quintiles, the world’s largest biopharmaceutical services company, is working with the National Football League (NFL) to track player injuries and understand trends in injury occurrence. Quintiles and the NFL have been working together since 2011, when the Quintiles epidemiology group was tasked with designing a new application that would modernize the league’s existing Injury Surveillance System (ISS). The NFL recently signed a five-year agreement with Quintiles to continue and expand upon its Injury Surveillance and Analytics (ISA) service as it is now known. Quintiles records injury occurrence during pre-season training, and continues throughout the regular season and playoffs. For the 2014-15 season, Quintiles began conducting injury...
Read More
Press Release Feb 06, 2015
RESEARCH TRIANGLE PARK, NC – February 6, 2015 – Quintiles Transnational Holdings Inc. (“Quintiles” or the “Company”) (NYSE: Q) announced today that its Board and principal shareholders have reached agreement on a governance plan to transition the Company’s Board of Directors and its committees to comply with NYSE criteria as a non-controlled company. Quintiles’ Stockholders Agreement has been amended, calling for the Quintiles Board to be set at nine members, comprised of a majority of independent directors by November 2015. In the interim, the Board size will be increased to 13 to make room for two additional independent directors, the first of whom is Dr. John Leonard, an experienced pharmaceutical development executive, who was appointed to the Board on February 5, 2015. Commencing in...
Read More
Press Release Feb 06, 2015
RESEARCH TRIANGLE PARK, NC – February 6, 2015 – Quintiles Transnational Holdings Inc. (“Quintiles” or the “Company”) (NYSE: Q) announced today that Dr. John Leonard, MD, has been appointed to its Board of Directors, effective immediately.  Dr. Leonard will also serve as a member of the Audit and Governance Committees of the Board.   Dr. Leonard serves as chief medical officer for Cambridge, MA-based Intellia Therapeutics, a private biotech company, in a position he has held since 2014.  Prior to Intellia, Dr. Leonard served as the chief scientific officer and senior vice president of research and development at AbbVie Inc., a global pharmaceutical company, since its spin-out from Abbott Laboratories in January 2013 until retiring from those positions at the end of 2013. Prior to the...
Read More
Press Release Jan 22, 2015
SEOUL – January 23, 2015 – Quintiles today announced the launch of a handbook to guide physicians in the conduct of investigator initiated clinical trials. Top clinical researchers from academia and industry across Asia-Pacific joined Quintiles’ experts in contributing to and editing the handbook, which Quintiles sponsored as part of its ongoing efforts to enhance clinical research globally and create a healthier world. Availability of the handbook, “Investigator Initiated Trials Made Easy,” was announced at a press conference held at Seoul National University Hospital in South Korea. “Investigator initiated, patient-focused clinical trials play a vital role in improving and expanding patient care in the real world,” said Dr. Stephanie Tan, MBBS, Quintiles Site and Patient Network, Asia,...
Read More
Press Release Jan 19, 2015
RESEARCH TRIANGLE PARK, N.C. – January 19, 2015 – Quintiles Transnational Holdings Inc. (NYSE: Q) will release its fourth-quarter 2014 financial results Thursday, February 12, 2015 prior to its quarterly earnings call at 8:00 a.m. EST. The conference call will be accessible, live via webcast, on the Investor Relations section of the Quintiles website at www.quintiles.com/investors. To participate via telephone, please dial +1 (855) 484-7367 in the United States or +1 (631) 259-7541 outside the United States, approximately 15 minutes before the scheduled start of the call. An archived edition of the conference call will be available online at www.quintiles.com/investors after 1:00 p.m. EST on Thursday, February 12th. About Quintiles Quintiles (NYSE: Q), a Fortune 500 company, is the...
Read More
Press Release Jan 15, 2015
RESEARCH TRIANGLE PARK, N.C. – January 15, 2015 – Expression Analysis (EA), a Quintiles company, today announced the winners of a grant program that provides scientists with leading-edge products and services to advance genomics research. In this sixth year of the program, EA and co-sponsor, Illumina, awarded two fully funded research grants to investigate genomic data locked within Formalin-Fixed, Paraffin Embedded (FFPE) tumor samples – a largely untapped data pool that can help enhance researchers’ understanding of cancer biology.  After a rigorous review of nearly 700 submissions by a distinguished panel of judges, two researchers were selected to receive grants. The recipients include: Professor Anne Bowcock, Ph.D., chair of Cancer Genomics at Imperial College London, who will...
Read More
Press Release Dec 17, 2014
RESEARCH TRIANGLE PARK, N.C. – December 17, 2014 – Quintiles CEO Tom Pike will present at the 2015 J.P. Morgan Healthcare Conference on Wednesday, January 14, 2015 in San Francisco at the Westin St. Francis Hotel. The Quintiles presentation will begin at 9:00 a.m. PST. Investors may access a live audio webcast of the presentation on the Quintiles’ Investor Relations website at www.quintiles.com/investors. An archived audio version of the presentation will be available later that day. About Quintiles Quintiles (NYSE: Q), a Fortune 500 company, is the world’s largest provider of biopharmaceutical development and commercial outsourcing services. With a network of more than 32,000 employees conducting business in approximately 100 countries, we helped develop or commercialize all of 2013’s...
Read More
Press Release Dec 08, 2014
SINGAPORE – December 9, 2014 – For the sixth time in eight years, Quintiles has been named Asia-Pacific Contract Research Organization of the Year by Frost & Sullivan, a leading business research and consulting firm. The award honors the CRO that scores the highest in Frost & Sullivan’s evaluation of several performance categories, including customer service; price/performance value; pioneering best practices; and addressing unmet needs. Frost & Sullivan cited Quintiles’ local market knowledge; its Asia-Pacific capabilities that complement its global offering; and its ability to provide solutions to meet customers’ most pressing needs as some of the reasons why Quintiles was selected as 2014 CRO of the Year. “I’d like to thank our 10,000 employees across Asia-Pacific for their efforts –...
Read More
Press Release Dec 04, 2014
RESEARCH TRIANGLE PARK, N.C.  – December 4, 2014 – Quintiles today announced that the company was awarded “Best Contract Research Organization” at the annual SCRIP Awards for the third year in-a-row. This is the company’s fourth award received in this category in the last five years. The SCRIP Awards acknowledge excellence in the biopharmaceutical industry, based on judging by an independent panel of 12 life sciences experts. “Our judges felt Quintiles was a worthy winner of the Best Contract Research Organization trophy for the third year in a row,” said Mike Ward, global director of content for IBI Pharma News & Datamonitor Healthcare.  “In the qualifying year, Quintiles once again demonstrated a series of performance milestones in its quest to improve its customers' probability of...
Read More
Press Release Dec 01, 2014
RESEARCH TRIANGLE PARK, N.C. – Dec. 1, 2014 – Quintiles today announced a new offering that combines its industry-leading pharmacovigilance, regulatory dossier/label maintenance, benefit-risk management, and analytic expertise into one integrated solution. This solution will help biopharmaceutical companies better manage all activities required to maintain the licenses for their portfolio of marketed products.  Underpinned by a fully-integrated technology platform, the new offering, called Marketed Product Maintenance (MPM), will provide biopharmaceutical companies with greater data-driven insights on the benefit-risk profiles of their products. These enhanced insights will enable customers to identify potential product risks, fulfill increasingly complicated regulatory requirements and...
Read More
Press Release Nov 19, 2014
SEOUL, SOUTH KOREA – November 19, 2014 – Quintiles announced today that it has been recognized as one of South Korea’s Best Workplaces by the Great Place to Work® Institute. This is Quintiles Korea’s first time to receive the award; it joins many other Quintiles’ offices worldwide similarly honoured by the Great Place to Work Institute. Quintiles Korea was a “Grand Award” winner – the highest level – from among more than 100 companies in South Korea that participated in this year’s study. The Great Place to Work Institute annual ranking is a comprehensive study of organizational culture and also the world’s largest and most respected study of workplace excellence and people management practices. MiSook Hyun, General Manager of Quintiles Korea, said: “This award affirms our efforts to...
Read More
Press Release Nov 07, 2014
RESEARCH TRIANGLE PARK, NC – November 7, 2014 – Quintiles CEO Tom Pike will present at the Credit Suisse Healthcare Conference on Tuesday, November 11, 2014 in Phoenix at the Arizona Biltmore. The Quintiles presentation will begin at 10:00 a.m. (MST). Investors may access a live audio webcast of the presentation on the Quintiles’ Investor Relations website at www.quintiles.com/investors. An archived audio version of the presentation will be available later that day. About Quintiles Quintiles (NYSE: Q), a Fortune 500 company, is the world’s largest provider of biopharmaceutical development and commercial outsourcing services. With a network of more than 32,000 employees conducting business in approximately 100 countries, we helped develop or commercialize all of 2013’s top-100 best-selling...
Read More
Press Release Nov 04, 2014
RESEARCH TRIANGLE PARK, N.C. – November 4, 2014 – Quintiles Transnational Holdings Inc. (“Quintiles”) (NYSE: Q) announced today the launch of an underwritten, secondary public offering of 13,303,666 shares of its common stock by certain of its existing shareholders, including investment funds associated with Bain Capital Investors, LLC, affiliates of TPG Global, LLC, affiliates of 3i Corporation and Dennis Gillings, CBE, and his affiliates (the “Selling Shareholders”), of which Quintiles intends to repurchase from the underwriter a number of shares having an aggregate value of approximately $250 million. Quintiles is not offering any stock in this transaction and will not receive any proceeds from the sale of the shares by the Selling Shareholders in this offering.  Quintiles’ per-share...
Read More
Press Release Oct 30, 2014
Research Triangle Park, NC – October 30, 2014 – Quintiles Transnational Holdings Inc. (“Quintiles” or the “Company”) (NYSE: Q) today reported its financial results for the third quarter ended September 30, 2014. 13.8% consolidated service revenue growth - Integrated Healthcare Services segment grew service revenues by 32.6% compared to the third quarter of 2013 Consolidated book-to-bill ratio of 1.42 results from 12.8% growth in net new business compared to the third quarter of 2013 Third quarter diluted adjusted EPS increased 22.6% to $0.65 per share compared to the third quarter of 2013 Third quarter GAAP reported diluted EPS increased 42.0% to $0.71 per share compared to the third quarter of 2013 Adjusted full year 2014 service revenue guidance of...
Read More
Press Release Oct 28, 2014
HOUSTON – October 28, 2014 – Modern Healthcare has ranked Encore, A Quintiles Company (formerly Encore Health Resources), in the top 10 of the publication’s 100 Best Places to Work in Healthcare for healthcare suppliers. Encore, a leader in the health-information analytics and technology consulting services focused on healthcare providers, has been recognized on this coveted list every year since the company began operations in 2009. “I am tremendously proud of the company and our employees who truly make Encore a great place to work,” said Dana Sellers, CEO, Encore, A Quintiles Company. “This ranking is particularly special because it’s based almost entirely on information from our own staff – the people who have rolled up their sleeves, done great work for our clients and have helped...
Read More
Press Release Oct 14, 2014
RESEARCH TRIANGLE PARK, NC – October 14, 2014 – Quintiles today announced that the company was awarded the Society for Clinical Research Sites’ (SCRS) 2014 Clinical Research Organization (CRO) Eagle Award. The award, which recognizes outstanding leadership, professionalism, integrity, passion and dedication, was presented during the annual SCRS Site Solutions Summit. "It is such an honor to be recognized again and receive this award for the second year in a row,” said Lindy Jones, senior vice president, Integrated Site Services, Quintiles. “Our ambition of transforming clinical development and accelerating pipelines to achieve better patient outcomes is only possible through the dedication and hard work of our investigators and sites. I would like to thank the investigators who voted for...
Read More